Pharma R&D cuts not as bad as reported

There has been a lot of discussion recently about the job cuts that we are seeing in the Pharma industry. But while the situation is admittedly tough for the people who are being laid-off, the truth is the industry as a whole is still in pretty good shape. As reported in FierceBiotech on 4/9, while there have been cuts,:

The money spent on R&D in the U.S. continues to rise, but after an 11.3 percent hike in 2006 budgets rose only 2.7 percent to a still considerable $35.4 billion.

Again, the industry still experiencing difficulties, but it is by no means decimated. While growth in R&D spending has slowed...the reality is...there still is growth!! While it is easy to get caught up in all the negative press we see about the industry, some times we do need to stop and take a look at the bright side.